1.
Rees MJ, Quach H, Jardine D, Thompson A. Response to Comment on: “Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies”. Haematologica 2026;111(4):1507-1508; https://doi.org/10.3324/haematol.2025.289053.